Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment
- 1 April 2006
- journal article
- Published by Elsevier in The Lancet
- Vol. 367 (9520) , 1399-1404
- https://doi.org/10.1016/s0140-6736(06)68546-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prophylaxis against RabiesNew England Journal of Medicine, 2004
- Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and ArenavirusesJournal of Virology, 2004
- Effectiveness of Postexposure Vaccination for the Prevention of Smallpox: Results of a Delphi AnalysisThe Journal of Infectious Diseases, 2003
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primatesNature, 2003
- Can Postexposure Vaccination against Smallpox Succeed?Clinical Infectious Diseases, 2003
- Rabies re-examinedThe Lancet Infectious Diseases, 2002
- Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV ChallengeJournal of Virology, 2001
- Resistance to and Recovery from Lethal Influenza Virus Infection in B Lymphocyte–deficient MiceThe Journal of Experimental Medicine, 1997
- The influence of virus structure on antibody responses and virus serotype formationImmunology Today, 1996
- T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice.The Journal of Experimental Medicine, 1996